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Table I. Demographic and clinical data
Demographic and clinical data of all study patients
Radial group
(n=130)
Femoral group
(n=130) P value
Age 66.88.9 66.710.2 0.856
Male (%) 60.8 65.4 0.441
Hypertension (%) 77.7 88.5 0.021
Hyperlipidaemia
(%)
56.2 47.7 0.172
Diabetes mellitus
(%)
36.2 36.9 0.898
Obesity (%) 14.6 34.6 0.0003
Smoker (%) 28.5 26.9 0.889
Peripheral artery
disease (%)
13.9 13.8 1.000
Coronary artery
disease (%)
24.6 24.6 0.776
Positive family
history (%)
6.9 9.2 0.495
Dialysis (%) 6.2 3.1 0.237
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Background: Carotid artery stenting (CAS) has become an alternative for carotid
endarterectomy in the treatment of carotid arteries atherosclerosis due to low
procedural injury and comparable procedural risk. Patients with coronary artery
disease have a higher risk of surgical treatment than in CAS procedure. The impact
of coronary artery disease (CAD) during long term follow-up (FU) needs reconsi-
dering due to the intensiﬁcation of aggressive pharmacotherapy in CAD during
recent years.
Methods: Data of 130 symptomatic and asymptomatic patients undergoing CAS
from January 2002 to December 2010 were divided in two groups: with and without
CAD. All CAS procedures were performed with application of cerebral protection
devices. Major adverse cardio and cerebrovascular events (MACCE) during follow-
up were deﬁned as combination of death (cardiac and non-cardiac), myocardial
infarction and stroke/TIA. Long-term outcomes of patients were stratiﬁed based on
history of CAD.
Results: The mean age of patients was 669 years, majority of patients were male
(80.2%). Long-term follow-up data were available in 86.2% of patients. During mean
follow-up of 71.931.7 months all-cause mortality rate was 19.6%. The rates of
myocardial infarction, stroke/TIA, and MACCE - were 14.3%, 11.6%, and 37.5%
respectively. The frequency of MACCE during long-term follow-up was higher in
patients with CAD vs without CAD (40.8% vs 6.7%,p ¼ 0.01) and the mortality rate
in the two groups was (22.2% vs 0%, p ¼ 0.07) respectively.
Conclusions: Patients with symptomatic or asymptomatic carotid stenosis are a high-
risk individuals with many coexisting diseases. The presence of CAD increases the
risk of MACCE in such patients during long-term follow-up.
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Background: Current guidelines recommend to perform Carotid Artery Stenting
(CAS) procedures with embolic protection devices (EPDs). Among these, prox-
imal EPDs such as the endovascular clamping (MO.MA. Medtronic INC) have the
advantage of providing embolic protection during all phases of the intervention.
However, endovascular clamping of the common carotid artery can expose theB154 JACC Vol 62/18/Suppl B j October 27–November 1, 2ipsilateral hemisphere to hypoperfusion and produce transient neurological
symptoms (clamping intolerance). The aim of the present study was to identify
the predictors of developing carotid clamping intolerance during CAS with
MO.MA.
Methods: From March 2010 to March 2012, 605 consecutive patients underwent
CAS using MO.MA. as EPD at our institution. Clamping intolerance was deﬁned as
any transient neurological deﬁcit observed during occlusion time, but showing
a complete recovery within 20 min after restoring antegrade ﬂow. To identify
predictors of clamping intolerance a logistic regression model was developed
including all patients' clinical characteristics, the presence of ICA stenosis >90%, the
presence of ipsilateral ECA stenosis, the presence of contralateral ICA stenosis (75-
99%) and occlusion, clamping pressure 40 mmHg, and arterial pressure delta >50
mmHg.
Results: 184 patients (30.4%) developed clamping intolerance during the CAS
procedure. Compared to patients without clamping intolerance, those who experienced
intolerance showed a lower clamping pressure (42.312.7 vs 61.9 5.4 mmHg,
p<0.001). ROC curve analysis showed that clamping pressure was the most consistent
predictor with a c-statistic of 0.85 (95% CI 0.82-0.88) and best cut-off being 40
mmHg (sensitivity 68.5%, speciﬁcity 93.3%). Logistic regression analysis showed
that the most powerful independent predictor of clamping intolerance was a clamping
pressure 40 mmHg (HR¼34.2, 95% CI 19.7-59.6) and that the most powerful
clinical predictor of such clamping pressure was the presence of contralateral ICA
occlusion (HR¼3.1, 95% CI 1.5-6.2).
Conclusions: Clamping intolerance may occur in up to a third of the patients
undergoing CAS with endovascular clamping. This event is more common in those
patients presenting a clamping pressure 40 mmHg.
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Background: It is not known whether racial or ethnic disparities observed with other
revascularization procedures are also seen with carotid artery stenting (CAS) and
endarterectomy (CEA).
Methods: We compared the utilization of CAS and CEA across racial/ethnic groups
within the CARE Registry between May 2005 - Dec 2012. Differences in clinical
characteristics, procedural variables, and major adverse cardiac and cerebrovascular
events (MACCE) were studied.
Results: Between 2005 and 2012, of the 13,129 patients who underwent CAS,
majority were non-Hispanic Caucasians (NHC 89.3%), followed by African Ameri-
cans (AA 4.4%), Hispanics (H 4.3%), and other groups (OG 2.0%). A similar
distribution was observed among the 10,953 patients undergoing CEA (NHC 92.6%,
AA 3.5%, H 2.8%, and OG 1.1%). During this time period, a trend toward propor-
tionate increase in CAS utilization was observed in NHC and OG whereas the
opposite was observed among H and AA (Fig 1). This trend persisted even when
hospitals performing both CAS and CEA were exclusively analyzed. Adherence to
anti-platelet and statin therapy was signiﬁcantly lower among AA post-CEA. In-
hospital MACCE remained comparable across groups post-CAS whereas post CEA,
there was a signiﬁcant decline in MACCE among NHC only (p¼0.04). At 30 days, the
incidence of death (2.2%), stroke (7.2%), and MACCE (8.8%) was higher among AA
post-CEA (p<0.05).013 j TCT Abstracts/POSTER/Carotid and Neurovascular Intervention
